RxDoctor Payments Data

Matthew Stevens, MD

Otolaryngology · Tupelo, MSNPI 1447494570

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.

$2,367in general payments, 2019–2025

Across 74 payments — averaging $31.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$396
  • Sanofi$384
  • Inspire Medical Systems, Inc.$320
  • Aerin Medical Inc.$221
  • Intersect ENT, Inc.$213
  • GSK$205
  • plus $627 from 12 others

What the payments were for

  • Food & beverage$2,367100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,367 in reported general payments places this provider in the 70th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$377,192
Medicare patients
636
Services billed
2,371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide238$6,061
Azelastine Hcl234$5,353
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,523
Montelukast Sodium255$1,310
Doxycycline Hyclate77$785
Mometasone Furoate74$761
Fluticasone Propionate65$698
Tobramycin-DexamethasoneTobramycin/Dexamethasone16$611
Famotidine100$517
Ofloxacin31$493
Levocetirizine Dihydrochloride70$424
Mupirocin49$393
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$288
Clotrimazole11$270
Levothyroxine Sodium63$203

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →